MedTrace Logo

BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study

NCT02537730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2020-08-18

Study results available
· View outcomes & findings →

Summary

Two week, Open Label, randomized, bilateral, crossover, 1 week of daily wear in each combination (lens / disinfecting cleaning system).

Conditions

  • Myopia

Interventions

DEVICE

Bioclean MPS VII

PHMB (Polyhexamethylene biguanide) base Disinfecting and Cleaning system

DEVICE

Aosept Clearcare

Hydrogen Peroxide Disinfecting and Cleaning system

DEVICE

comfilcon A

contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Yuji Kodama, MD, PhD · Kodama Eye Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-10-31
Completion
2016-06-30
FDA Device
Yes

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537730 on ClinicalTrials.gov